The Association of Innovative Pharmaceutical Manufacturers (AIPM) wants to reach an agreement with the government on improving the level of healthcare in Hungary, the association’s new chairman Zoltán Jakab said in an interview in Tuesday’s issue of business daily Világgazdaság. Hungarian drugmakers will have to band together to reach a mid-term agreement with the government, Jakab said, adding that it was hoped an accord could be reached on the matter with the National Association of Hungarian Pharmaceutical Manufacturers (MAGyOSz) and the Association of Generic Pharmaceutical Manufacturers. Spending on healthcare in Hungary is about 4% of GDP, well under the 6% average for the Visegrád Group, he said.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
